scholarly journals Hypophosphatemic Osteomalacia with Multiple Bone Fractures: ADV-Induced Fanconi's Syndrome

2018 ◽  
Vol 54 (1) ◽  
pp. 78
Author(s):  
Jee Hyuk Kim ◽  
Heung Yong Jin ◽  
Hong Sun Baek ◽  
Kyung Ae Lee
2019 ◽  
Vol 139 (4) ◽  
pp. 641-645 ◽  
Author(s):  
Takashi Makita ◽  
Hirotaka Kanzaki ◽  
Hideki Onishi ◽  
Ailee Ikeda ◽  
Akinobu Takaki ◽  
...  

2014 ◽  
Vol 53 (3) ◽  
pp. 233-237 ◽  
Author(s):  
Hiroyuki Eguchi ◽  
Munehisa Tsuruta ◽  
Junichi Tani ◽  
Reiichiro Kuwahara ◽  
Yuji Hiromatsu

2019 ◽  
Author(s):  
Mohsin Siddiqui ◽  
Michael Rayment ◽  
Hannah Kilbride ◽  
Ratan Gor ◽  
Kevin Shotliff ◽  
...  

Author(s):  
Yu Zhang ◽  
Jianfei Long ◽  
Shuangmei Tong ◽  
Wang Bin

This is the first case of adefovir dipivoxil (ADV)-induced hypophosphatemic osteomalacia (HO) and Fanconi’s syndrome in which bone mineral density (BMD) is continuously reduced after drug discontinuation. Sustained elevation of urine β2-MG also supports the recent view that ADV-induced renal injury is not completely reversible.


2014 ◽  
Vol 103 (6) ◽  
pp. 1388-1390 ◽  
Author(s):  
Kazutoshi Hirose ◽  
Yoshifumi Ubara ◽  
Rikako Hiramatsu ◽  
Naoki Sawa ◽  
Eiko Hasegawa ◽  
...  

2007 ◽  
Vol 30 (2) ◽  
pp. 101 ◽  
Author(s):  
Hye Sung Won ◽  
In Jeong Cho ◽  
Seung Hyun Yoo ◽  
Mi Na Yu ◽  
Dong Ryeol Ryu ◽  
...  

2020 ◽  
pp. 5112-5123
Author(s):  
Nine V.A.M. Knoers ◽  
Elena N. Levtchenko

Glycosuria—glucose reabsorption in the proximal tubule is carried out by two different pairs of apical Na+-dependent (SGLT1 and -2) and basolateral Na+-independent (GLUT1 and -2) glucose transporters. Abnormalities in renal glucose transport can be seen in association with other defects of proximal tubular transport. Familial renal glycosuria is a rare autosomal recessive condition caused by mutations in the SGLT2-encoding gene, SLC5A2. Phosphate-handling disorders—the plasma concentration of inorganic phosphate depends on the balance between intestinal absorption, renal excretion, and the internal contribution from bone. Changes of serum phosphate levels can be caused by numerous inherited and acquired conditions. Disorders associated with increased urinary phosphate excretion and low serum phosphate levels produce symptoms that mainly affect the bones: rickets in children and osteomalacia in adults. Magnesium-handling disorders—normal plasma magnesium concentration is achieved by variation of urinary magnesium excretion in response to altered uptake by the intestine. The main site of magnesium absorption is the small bowel, via paracellular simple diffusion at high intraluminal concentrations, and via active transcellular uptake through the magnesium channel TRPM6 at low concentrations. Regulation and fine-tuning of serum magnesium concentration occurs primarily in the kidney. Genetic disorders of magnesium handling include Gitelman’s syndrome. Aminoaciduria and renal Fanconi’s syndrome—most amino acids (except for tryptophan, which is protein bound) are freely filtered by the glomerulus, after which 95 to 99.9% are reabsorbed in the proximal tubules by apical Na+-dependent cotransporters and Na+-independent cotransporters. Aminoaciduria is defined as urinary excretion of more than 5% of the filtered load of an amino acid. Renal Fanconi’s syndrome is characterized by a generalized defect of both Na+-coupled and receptor-mediated proximal tubular transport.


1991 ◽  
Vol 9 (8) ◽  
pp. 1495-1499 ◽  
Author(s):  
C B Pratt ◽  
W H Meyer ◽  
J J Jenkins ◽  
L Avery ◽  
C P McKay ◽  
...  

Three of 218 children treated with ifosfamide plus the uroprotectant mesna, in single- or combination-agent protocols, have developed Fanconi's renal syndrome, all of whom were in a subgroup of 86 children who had also received cisplatin or carboplatin therapy. Patients receiving ifosfamide who have received prior cisplatin (or carboplatin) are at significantly higher risk of developing Fanconi's syndrome than are those who have received no prior nephrotoxic therapy (P = .04). The role of prior nephrotoxic therapy, including cisplatin and its derivatives, and the total dose of ifosfamide should be considered in the assessment of this rare but serious and apparently irreversible side effect.


Blood ◽  
1959 ◽  
Vol 14 (9) ◽  
pp. 1008-1014 ◽  
Author(s):  
SERGIO GARRIGA ◽  
WILLIAM H. CROSBY

Abstract The authors have reviewed the published cases of Fanconi’s syndrome of hypoplasia of the bone marrow. They have tabulated the features of the syndrome, pointing out that atrophy of the spleen is a common fault and may reflect a generalized dystrophy of the tissues of mesenchymal origin. Of special interest is the demonstration of a high incidence of leukemia in the families of patients with hereditary hypoplasia of the bone marrow.


Sign in / Sign up

Export Citation Format

Share Document